Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: A pivotal role for stromelysin-1 in cartilage destruction

Journal of Immunology

Volumn 163, Issue 10, 1999, Pages 5633-5639

  Van Meurs, Joyce ^a   Van Lent, Peter ^a   Holthuysen, Astrid ^a   Lambrou, Dimitri ^a   Bayne, Ellen ^b   Singer, Irwin ^b   Van Den Berg, Wim ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; STROMELYSIN;

ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ANIMALS; ARTHRITIS; CARTILAGE, ARTICULAR; ENZYME ACTIVATION; EPITOPES; IMMUNE COMPLEX DISEASES; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS;

EID: 0033571757     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Arner, E. C., M. A. Pratta, J. M. Trzaskos, C. D. Decicco, and M. D. Tortorella. 1999. Generation and characterization of aggrecanase: a soluble, cartilage-derived aggrecan-degrading activity. J. Biol. Chem. 274:6594.
2. Flannery, C. R., M. W. Lark, and J. D. Sandy. 1992. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan: evidence for proteolysis at this site in vivo in human articular cartilage. J. Biol. Chem. 267:1008.
3. Fosang, A. J., P. J. Neame, K. Last, T. E. Hardingham, G. Murphy, and J. A. Hamilton. 1992. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J. Biol. Chem. 267:19470.
4. Fosang, A. J., K. Last, V. Knauper, P. J. Neame, G. Murphy, T. E. Hardingham, H. Tschesche, and J. A. Hamilton. 1993. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem. J. 295:273.
5. Fosang, A. J., K. Last, V. Knauper, G. Murphy, and P. J. Neame. 1996. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380:17.
6. Chander, C. L., and F. M. Desa. 1991. The effects of estrogens on cartilage degradation using in vivo and in vitro models. Agents Actions 34:282.
7. Lark, M. W., E. K. Bayne, J. Flanagan, C. F. Harper, L. A. Hoerrner, N. I. Hutchinson, I. I. Singer, S. A. Donatelli, J. R. Weidner, H. R. Williams, R. A. Mumford, and L. S. Lohmander. 1997. Aggrecan degradation in human cartilage: evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic and rheumatoid joints. J. Clin. Invest. 100:93.
8. Fosang, A. J., K. Last, and R. A. Maciewicz. 1996. Aggrecan is degraded by matrix metalloproteinases in human arthritis: evidence that matrix metalloproteinase and aggrecanase activities can be independent. J. Clin. Invest. 98:2292.
9. Lohmander, L. S., P. J. Neame, and J. D. Sandy. 1993. The structure of aggrecan fragments in human synovial fluid: evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 36:1214.
10. Singer, I. I., D. W. Kawka, E. K. Bayne, S. A. Donatelli, J. R. Weidner, H. R. Williams, J. M. Ayala, R. A. Mumford, M. W. Lark, T. T. Glant, et al. 1995. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J. Clin. Invest. 95: 2178.
11. Singer, I. I., S. Scott, D. W. Kawka, E. K. Bayne, J. R. Weidner, H. R. Williams, R. A. Mumford, M. W. Lark, J. McDonnell, A. Christen, V. L. Moore, J. S. Mudgett, and D. M. Visco. 1997. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen induced arthritis. Osteoarthritis Cartilage 5:407.
12. van Meurs, J. B. J., P. L. E. M. van Lent, I. I. Singer, E. K. Bayne, A. A. J. van de Loo, and W. B. van den Berg. 1998. Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis. Arthritis Rheum. 41:647.
13. van Meurs, J. B. J., P. L. E. M. van Lent, A. E. M. Holthuysen, I. I. Singer, E. K. Bayne, and W. B. van den Berg. 1999. Kinetics of aggrecanese- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum. 42:1128.
14. Stoop, R., J. B. J. van Meurs, I. I. Singer, E. K. Bayne, A. R. Poole, R. C. Billinghurst, P. Buma, P. L. E. M. van Lent, P. M. van der Kraan, and W. B. van den Berg. 1998. The collagenase cleavage site in type II colocalizes with the MMP-generated aggrecan neo-epitope VDIPEN in murine antigen induced arthritis. Orthop. Res. Soc. 23:851 (Abstr.).
15. van Meurs, J. B. J., P. L. E. M. van Lent, A. E. M. Holthuysen, R. Stoop, I. I. Singer, E. K. Bayne, D. Visco, J. S. Mudgett, and W. B. van den Berg. 1998. Expression of the MMP induced neoepitope VDIPEN is linked to severe cartilage damage: an essential role for stromelysin in antigen induced arthritis. Orthop. Res. Soc. 23:856 (Abstr.).
16. McAnulty, R. J., and G. J. Laurent. 1990. In vivo measurement of collagen metabolism in cartilage and bone. In Methods in Cartilage Research. A. Maroudas and K. Kuettner, eds. Academic Press, San Diego, CA, p. 140.
17. Matrisian, L. M. 1992. The matrix-degrading metalloproteinases. Bioessays 14: 455.
18. Murphy, G., M. I. Cockett, R. V. Ward, and A. J. Docherty. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277:277.
19. Brinckerhoff, C. E., K. Suzuki, and T. I. Mitchell. 1990. Rabbit procollagenase synthesized and secreted by a high yield mammalian expression vector requires stromelysin (matrix metalloproteinase-3) for maximal activation. J. Biol. Chem. 265:22262.
20. van Lent, P. L. E. M., L. van den Bersselaar, A. E. M. van den Hoek, A. A. J. van de Loo, and W. B. van den Berg. 1992. Cationic immune complex arthritis in mice - a new model: synergystic effect of complement and interleukin-1. Am. J. Pathol 140:1451.
21. van Lent, P. L. E. M., A. A. J. van de Loo, A. E. M. Holthuysen, L. A. M. van den Bersselaar, H. Vermeer, and W. B. van den Berg. 1995. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J. Rheumatol. 22:2250.
22. Mudgett, J. S., N. I. Hutchinson, N. A. Chartrain, A. J. Forsyth, J. McDonnell, I. I. Singer, E. K. Bayne, J. Flanagan, D. Kawka, C. F. Shen, K. Stevens, H. Chen, M. Trumbauer, and D. M. Visco. 1998. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 41: 110.
23. Schalkwijk, J., L. B. A. van de Putte, and L. A. Joosten. 1987. Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by α-1-proteinase inhibitor. Br. J. Exp. Pathol. 68:81.
24. Fosang, A. J., K. Last, P. Gardiner, D. C. Jackson, and L. Brown. 1995. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem. J. 310:337.
25. 1 fragment using monospecific anti-peptide serum. Biochem. J. 307:245.
26. Hughes, C. E., B. Caterson, A. J. Fosang, P. J. Roughley, and J. S. Mort. 1995. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem. J. 305:799.
27. Ugai, K., H. Ishikawa, K. Hirohata, and H. Shirane. 1983. Interaction of polymorphonuclear leukocytes with immune complexes trapped in rheumatoid articular cartilage. Arthritis Rheum. 26:1434.
28. Jasin, H. E. 1985. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 28:241.
29. Veto, A. A., M. Mannila, E. Zatavain-Rios, and M. H. Weber. 1990. Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis. Rheumatol. Int. 10:13.
30. Campbell, E. J., E. K. Silverman, and M. A. Campbell. 1989. Elastase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:2961.
31. Kowanko, I. C., and A. Ferrante. 1996. Adhesion and TNF priming in neutrophil-mediated cartilage damage. Clin. Immunol. Immunopathol. 79:36.
32. Sandy, J. D., P. J. Neame, R. E. Boynton, and C. R. Flannery. 1991. Catabolism of aggrecan in cartilage explants: identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266:8683.
33. Ilic, M. Z., C. J. Handley, H. C. Robinson, and M. T. Mok. 1992. Mechanism of catabolism of aggrecan by articular cartilage. Arch. Biochem. Biophys. 294:115.
34. Loulakis, P., A. Shrikhande, G. Davis, and C. A. Maniglia. 1992. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures: putative site(s) of enzymic cleavage. Biochem. J. 284:589.
35. Arner, E. C., C. E. Hughes, C. P. decicco, B. Caterson, and M. D Tortorella. 1998. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase. Osteoarthritis Cartilage 6:214.
36. Moore, A. R., H. Iwamura, J. P. Larbre, D. L. Scott, and D. A. Willoughby. 1993. Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms. Ann. Rheum. Dis. 52:27.
37. Nagase, H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378:151.
38. Hollander, A. P., I. Pidoux, A. Reiner, C. Rorabeck, R. Bourne, and A. R. Poole. 1995. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J. Clin. Invest. 96:2859.
39. Hollander, A. P., T. F. Heatfield, C. Webber, Y. Iwata, R. Bourne, C. Rorabeck, and A. R. Poole. 1994. Increased damage to type II collagen in osteoarthritic cartilage detected by a new immunoassay. J. Clin. Invest. 93:1722.
40. Knauper, V., S. M. Wilhelm, P. K. Seperack, Y. A DeClerck, K. E. Langley, A. Osthues, and H. Tschesche. 1993. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem. J. 295:581.